feed,title,long_url,short_url
SeekingAlpha,"Orchard Therapeutics GAAP EPS of -$0.06 beats by $0.15, revenue of $6.97M beats by $1.66M",https://seekingalpha.com/news/3944320,
SeekingAlpha,Esperion stock slumps ~20% amid Nexletol data showing reduced risk of heart events,https://seekingalpha.com/news/3944318,
SeekingAlpha,TCRÂ² Therapeutics stock rise 41% after merger deal with Adaptimmune,https://seekingalpha.com/news/3944319,
SeekingAlpha,Lennar: Not The Right Time For This Homebuilder,https://seekingalpha.com/article/4584806,
